Organogenesis Holdings (ORGO) EBT: 2017-2025
Historic EBT for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $21.2 million.
- Organogenesis Holdings' EBT rose 263.39% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.2 million, marking a year-over-year increase of 58.24%. This contributed to the annual value of -$2.8 million for FY2024, which is 127.01% down from last year.
- Per Organogenesis Holdings' latest filing, its EBT stood at $21.2 million for Q3 2025, which was up 278.81% from -$11.8 million recorded in Q2 2025.
- In the past 5 years, Organogenesis Holdings' EBT registered a high of $21.2 million during Q2 2021, and its lowest value of -$25.8 million during Q1 2025.
- Over the past 3 years, Organogenesis Holdings' median EBT value was -$1.8 million (recorded in 2023), while the average stood at -$806,455.
- Per our database at Business Quant, Organogenesis Holdings' EBT surged by 670.88% in 2024 and then slumped by 493.67% in 2025.
- Over the past 5 years, Organogenesis Holdings' EBT (Quarterly) stood at $18.9 million in 2021, then crashed by 53.66% to $8.8 million in 2022, then slumped by 120.52% to -$1.8 million in 2023, then spiked by 670.88% to $10.3 million in 2024, then soared by 263.39% to $21.2 million in 2025.
- Its EBT stands at $21.2 million for Q3 2025, versus -$11.8 million for Q2 2025 and -$25.8 million for Q1 2025.